Pharmaceuticals, Biotechnology and Life Sciences
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced…
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced…
– New MGTA-117 antibody-drug conjugate (ADC) clinical candidate for conditioning demonstrated broad therapeutic index in data highlighted in oral presentation…
– New MGTA-117 antibody-drug conjugate (ADC) clinical candidate for conditioning demonstrated broad therapeutic index in data highlighted in oral presentation…
TORONTO–(BUSINESS WIRE)–NEO is pleased to announce it has granted final approval to Mind Medicine (MindMed) Inc. (“MindMed”), the leading neuro-pharmaceutical…
TORONTO–(BUSINESS WIRE)–NEO is pleased to announce it has granted final approval to Mind Medicine (MindMed) Inc. (“MindMed”), the leading neuro-pharmaceutical…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…
REVIVE-HF seeks to demonstrate superiority of the Revivent TC System to current guideline treatment for heart failure SAN RAMON, Calif.–(BUSINESS…
REVIVE-HF seeks to demonstrate superiority of the Revivent TC System to current guideline treatment for heart failure SAN RAMON, Calif.–(BUSINESS…
EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today…